Claim CME Credit

WEDNESDAY, MAY 3

8:00 am – 12:00 pm PRE CONGRESS SESSION I
*Additional Registration Fees May Apply.
  W11: Advanced Diabetes Technology Concepts
Chair: George Grunberger, MD
Room: 18A-D
CME Code: 3119
  W21: Hot Topics in Bone Disease in 2017: Building Better Bones
Chairs: Rachel Pessah-Pollack, MD; Daniel L. Hurley, MD
Room: 17B
CME Code: 7351
  W31: Providing Reproductive Endocrine Care in the Office
Chairs: Charles Faiman, MD; Rhoda H. Cobin, MD
Room: 16B
CME Code: 8492
  W41: Leading Edge of Practical Thyroidology
Chair: Mark Lupo, MD
Room: 19
CME Code: 7676
1:00 pm – 5:00 pm PRE CONGRESS SESSION II
*Additional Registration Fees May Apply.
  W12: Advanced Diabetes Technology Skills Practice
Room: 3119
CME Code: 6397
  W22: The Practice of Obesity Medicine in 2017
Chair: Ken Fujioka, MD; W. Timothy Garvey, MD
Room: 19
CME Code: 7145
  W32: Endocrinologist - Surgeon: Critical Collaboration with Case-Based Conversations
Chairs: Mira Milas, MD; Jeffrey Garber, MD
Room: 16B
CME Code: 4555
1:00 pm – 5:30 pm W42: AACE Board Review & MOC Course
Moderator: Pauline M. Camacho, MD
Speaker: Pauline M. Camacho, MD; Elise Brett, MD; Sethu K. Reddy, MD
Room:17B
CME Code:6703
5:30 pm – 7:45 pm

WSS1: Burning Questions about New and Emerging Injectable Therapies for Type 2 Diabetes: A Hot Topics Presentation

Supported by an educational grant from Novo Nordisk

Room: JW Marriott: Lonestar E-H
CME Code: 8770
 

WSS2: A Town Hall Series on Improving Access to PCSK9 Inhibitors: Issues and Recommendations Clinicians (Non-CME)

Supported by Amgen, Inc., Sanofi and Regeneron

Room: Lonestar A-D
CME Code:

THURSDAY, MAY 4

5:15 am – 7:30 am

TSS1: Continuous Glucose Monitoring as the Standard of Care: Clinical Outcomes, Improved Access and Non-Adjunctive Use

Supported by an educational grant from Dexcom
Room: JW Marriott: Lonestar E-H
CME Code:7291
 

TSS2: Current Landscape in Medullary Thyroid Cancer: Update for Clinicians

Supported by an educational grant from Genzyme, A Sanofi Company

Room: JW Marriott: Lonestar A-D
CME Code:9684
6:30 am - 6:00 pm Attendee Registration
7:00 am - 6:00 pm CME Station Hours
9:45 am - 2:15 pm Exhibit Hall Hours
8:00 am – 8:30 am General Session Announcements
8:30 am – 9:15 am TGS1: "But Why Bone?"
Moderator: Pauline M. Camacho, MD
Speaker: Gerard Karsenty, MD

Room: Ballroom D
CME Code: 1314
9:15 am – 10:00 am TGS2: Precision Medicine for Diabetes: Where Are We?
Moderator: Vivian Fonseca, MD
Speaker: Judith Fradkin, MD


Room: Ballroom D
CME Code: 7161
10:00 am – 11:00 am Young Investigator Poster Session in Exhibit Hall
10:15 am – 11:00 am Product Theaters in the Exhibit Hall (2)
11:05 am - 11:15 am Award Presentations
11:15 am – 12:00 pm TGS3: Diabetes Management: Applications of High Tech Innovations
Moderator: George Grunberger,MD
Speaker: William Tamborlane, MD

Room: Ballroom D
CME Code: 9822
12:00 pm – 1:00 pm Box Lunch with Exhibitors
12:00 pm – 12:45 pm Young Investigator ePoster Oral Presentations
12:30 pm – 2:15 pm Women's Luncheon: Female Physicians and the Future of Endocrinology
Moderator: Etie S. Moghissi, MD
Speaker: Ann Danoff, MD


Room: Ballroom E - G
12:45 pm – 1:30 pm Product Theater in the Exhibit Hall
1:15pm – 2:00 pm Product Theaters (2) in the Exhibit Hall
2:15 pm – 3:15 pm MEET-THE-EXPERTS SESSION I
  T11: Different Approach to Obesity in T1D vs. T2DM
Moderator: Scott Isaacs, MD
Speaker: Richard E. Pratley, MD


Room: 19
CME Code: 6550
  T21: Decision Support System for the Treatment of Diabetes (Non-CME)
Moderator: Kathleen Wyne, MD
Speaker: Moshe Phillip, MD


Room: 17B
  T31: Evolving to Precision Thyroid Cancer Care
Moderator: Steven A. De Jong, MD
Speaker: Matt Ringel, MD


Room: 18CD
CME Code: 8361
  T41: FRAX in Diabetes and Underserved Populations
Moderator: Anne Leddy, MD
Speaker: William Leslie, MD
Special Guest: John Kanis, MD


Room: 16A
CME Code: 4973
  T51: Transition for the Growth Hormone Treated Patient from the Pediatric to Adult Clinic
Moderator: Jay Cohen, MD
Speaker: Andrew Hoffman, MD


Room: 16B
CME Code: 3439
  T61: Approach to Pseudo Endocrine Patients
Moderator: William Zigrang, MD
Speaker: Michael Mcdermott, MD


Room: 18AB
CME Code: 6987
  T71: Personalized Diabetes Management: Cultural Considerations
Moderator: Jeffrey Mechanick, MD
Speaker: Osama Hamdy, MD;
Shashank Joshi, MD

Room: 17A
CME Code: 5324
3:15pm-3:30pm Coffee Break
3:30 pm – 4:30 pm MEET-THE-EXPERTS SESSION II
  T12: Interpreting Lipid Guidelines: How Low Should You Go?
Moderator: Chris Guerin, MD
Speaker: Yehuda Handelsman, MD; Paul S. Jellinger, MD


Room: 18AB
CME Code: 8246
  T22: Diabetic Foot: Diagnostic Innovations for the Endocrinologist
Moderator: Cheryl Rosenfeld, DO
Speaker: Andrew Boulton, MD


Room: 17A
CME Code: 2252
  T32: Endocrine Care of Oncology Patients
Moderator: Janet McGill, MD
Speaker: Conor Best, MD


Room: 17B
CME Code: 9260
  T42: Different Approach to Obesity in T1D vs T2DM
Moderator: Scott Isaacs, MD
Speaker: Richard E. Pratley, MD


Room: 19
CME Code: 6358
  T52: Evolving to Precision Thyroid Cancer Care
Moderator: Steven A. De Jong, MD
Speaker:Matt Ringel, MD


Room: 18CD
CME Code: 8175
  T62: FRAX in Diabetes and Underserved Populations
Moderator: Anne Leddy, MD
Speaker: William Leslie, MD
Special Guest: John Kanis, MD


Room: 16A
CME Code: 5648
  T72: Transition for the Growth Hormone Treated Patient from the Pediatric to Adult Clinic
Moderator: Jay Cohen, MD
Speaker: Andrew Hoffman, MD


Room: 16B
CME Code: 7613
4:30 pm – 4:45 pm Break
4:45 pm – 5:45 pm MEET-THE-EXPERTS SESSION III
  T13: Approach to Pseudo Endocrine Patients
Moderator: William Zigrang, MD
Speaker: Michael Mcdermott, MD


Room: 18CD
CME Code: 4896
  T23: Decision Support System for the Treatment of Diabetes (Non-CME)
Moderator: Kathleen Wyne, MD
Speaker: Moshe Phillip, MD


Room: 16A
CME Code: 4492
  T33: Personalized Diabetes Management: Cultural Considerations
Moderator: Jeffrey Mechanick, MD
Speaker: Osama Hamdy, MD;
Shashank Joshi, MD


Room: 16B
CME Code: 9022
  T43: Endocrine Care of Oncology Patients
Moderator: Janet McGill, MD
Speaker: Conor Best, MD


Room: 17B
CME Code: 1674
  T53: Diabetic Foot: Diagnostic Innovations for the Endocrinologist
Moderator: Cheryl Rosenfeld, DO
Speaker: Andrew Boulton, MD


Room: 17A
CME Code: 9313
  T63: Interpreting Lipid Guidelines: How Low Should You Go?
Moderator: Chris Guerin, MD
Speaker: Yehuda Handelsman, MD; Paul S. Jellinger, MD


Room: 18AB
CME Code: 9484
  T73: Learning From Legends
Moderator: Sethu Reddy, MD
Speaker: Edward Horton, MD


Room: 19
CME Code: 1626
6:00 pm – 7:00 pm Domestic & International Chapter Receptions
7:15 pm – 9:30 pm

TSS3: Using Insulin - When, Where and How It's Needed: Type 2 Diabetes Treatment in the Modern Age

Supported by an educational grant from Sanofi US

Room:JW Marriott: Lonestar E-H
CME Code: 9563
  TSS4: UPDATES ABOUND! Latest and Greatest in Practical Application of Cardiovascular Outcomes for Diabetes Drugs
Supported by an educational grant from AstraZeneca

Room: JW Marriott: Lonestar A-D
CME Code: 1614

FRIDAY, MAY 5

5:15 am – 7:30 am

FSS1: Standardized Glucose Reporting - The New EKG for Diabetes?

Supported by an educational grant from Abbott

Room: JW Marriott: Lonestar E-H
CME Code: 9519
7:30 am - 6:30 pm Attendee Registration
7:30 am - 6:00 pm CME Station Hours
10:30 am - 3:30 pm Exhibit Hall Hours
8:00 am - 8:15 am Award Presentations
8:20 am – 9:05 am FGS1: Osteoporosis: History of FRAX
Moderator: Steven M. Petak, MD
Speaker: John Kanis, MD


Room: Ballroom D
CME Code: 3955
9:15 am – 12:00 pm IN-DEPTH SYMPOSIA SESSION I
  F11: Heart Failure: The Frequent, Forgotten and Fatal Complication of Type 2 Diabetes
Chair: David Bell, MD
Room: 19
CME Code: 9720
  F21: The Transition Process: Key to Continued Best Endocrine Care
Chairs: Robert Rapaport, MD; Jay Cohen, MD
Room: 16B
CME Code: 9674
  F31: Innovations in Evaluation and Management of Adrenal Diseases
Chair: Karel Pacak, MD
Room: 18A-C
CME Code: 8269
  F41: Integrating Guidelines, Experience and Clinical Judgement in the Management of Thyroid Cancer
Chair: Peter Singer, MD
Supported by the Hossain Gharib, MD Educational Fund

Room: 17
CME Code: 5326
  F51: Practical Issues for Nurse Practitioners/Physician Assistants in an Endocrine Practice
Chairs: W. Reid Litchfield, MD; Sondra O’ Callaghan, PA
Room: 16A
CME Code: 2953
12:00 pm – 2:15 pm Exhibit Hall Break
12:00 pm – 1:00 pm Box Lunch with Exhibitors
12:00 pm – 12:45 pm ePoster Oral Presentations
12:30 pm – 2:15 pm Fellows-In-Training Luncheon
12:45 pm – 1:30 pm Product Theater in the Exhibit Hall
1:15 pm – 2:00 pm Product Theaters in the Exhibit Hall (2)
2:15 pm – 5:00 pm IN-DEPTH SYMPOSIA SESSION II
  F12: The Diabetic Foot: Clear and Unpleasant Danger
Chairs: Andrew Boulton, MD; David Armstrong, MD
Room: 16B
CME Code: 9674
  F22: State-of-the-Art Treatment of Obesity in Your Practice
Chairs: W. Timothy Garvey, MD; Michael Bush, MD
Room: 17
CME Code: 7807
  F32: Metabolic Bone Disease: What's New in 2017?
Chair: Pauline M. Camacho, MD
Room: 18A-C
CME Code: 2067
  F42: The Aging Patient: Endocrinology for the Ages
Chair: Robert M. Palmer, MD
Room:19
CME Code:9052
  F52: Sustaining Your Endocrine Practice
Chair: Richard Haas, MD
Room: 18D
CME Code: 5679
5:00 pm - 6:00 pm Open Discussion of Alternate Business Models for Endocrine Practices
  F62: Insulin Resistance in Latinos : A Nationwide Epidemic
Chairs: Myriam Allende- Vigo, MD; Valentin Sanchez, MD
In conjunction with SMNE

Room:16A
CME Code:9084
4:30 pm – 6:30 pm Poster-Viewing Wine & Cheese Reception in Exhibit Hall
5:00 pm – 6:15 pm Poster Session in Exhibit Hall
6:15 pm – 7:00 pm Product Theaters
7:00 pm – 9:15 pm

FSS3: Hypoparathyroidism: Evolving Presentation, Incorporating Guidelines and Optimizing Treatment

Supported by an educational grant from Shire

Room: JW Marriott: Lonestar E-H
CME Code: 4151
 

FSS4: Treatment Advances for Challenging Patients with Type 2 Diabetes: The Role of Emerging Insulin Combinations

Supported by an educational grant from Sanofi

Room: JW Marriott: Lonestar A-D
CME Code: 2457

SATURDAY, MAY 6

7:30 am -5:00 pm Attendee Registration
7:30 am -6:00 pm CME Station Hours
9:45 am -1:00 pm Exhibit Hall Hours
8:00 am – 8:10 am Poster Award Presentations
8:10 am – 8:15 am Award Presentation
8:15 am – 9:00 am SGS1: Evolution and Revolution of Radioiodine Refractory Thyroid Cancer
Moderator: Felice Caldarella, MD
Speaker: Steve Sherman, MD


Room: Ballroom D
CME Code: 2522
9:00 am - 9:15 am Award Presentations
9:15 am – 10:00 am SGS2: Advances in Pituitary
Moderator: Susan Samson, MD
Speaker: Anne Klibanski, MD


Room: Ballroom D
CME Code: 9167
9:15 am – 10:00 am SGS3: Select Abstract Oral Presentations I
Moderator: David C. Lieb, MD
AN ASSESSMENT OF EASE OF READABILITY OF ONLINE PATIENT EDUCATION MATERIAL ON THYROID CANCER TREATMENT: NOT SO READABLE AFTERALL
Rashika Bansal, MD

SIX YEAR CLINICAL AND IMAGING FOLLOW UP OF AN OFFICE BASED GENE EXPRESSION CLASSIFIER USED TO MANAGE THYROID NODULES
Brian Michael, MD

22 MONTH REVIEW OF IMMUNE CHECKPOINT INHBITOR ASSOCIATED ENDOCRINE DISORDERS AT A SOUTHERN CALIFORNIA TEACHING HOSPITAL
Lauren Clarine, DO

Room: 17A
CME Code: 8105
9:15 am – 10:00 am SGS4:Select Abstract Oral Presentations II
Moderator: Matthew J. Levine, MD
EFFECTS OF CANAGLIFLOZIN VERSUS GLIMEPIRIDE ON ADIPOKINES, INFLAMMATORY BIOMARKERS, AND CHEMOKINES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
W. Timothy Garvey, MD

CLINICAL PREDICTORS OF PROGRESSION TO INSULIN USE AMONG CHINESE PATIENTS WITH TYPE 2 DIABETES- THE HONG KONG DIABETES REGISTRY
Ronald Ma, MB, BCh.

VALUE OF CHRONIC DISEASE REGISTRY IN EVALUATING PREDICTORS FOR DIABETES-RELATED CLINICAL INERTIA
Wael Eid, MD

Room: 17B
CME Code: 6636
10:00 am – 11:00 am Late Breaking Poster Session in Exhibit Hall
10:15 am – 11:00 am> Product Theaters (2) in the Exhibit Hall
11:00 am – 11:10 am Award Presentations
11:15 am – 12:00 pm SGS5: Evidence Generation to Inform Medical Decisions
Moderator: Mack Harrell, MD
Speaker: Robert Califf, MD


Room: Ballroom D
CME Code: 1948
11:15 am – 12:00 pm SGS6: Late Breaking Oral Presentations (Non-CME)
Moderators: Lance Sloan, MD; Harmeet Singh Narula, MD REDICTABILITY OF DIABETES MELLITUS TYPE 2 REMISSION AND CHANGES IN METABOLIC PROFILE AFTER BARIATRIC SURGERY USING DIAREM SCORING SYSTEM
Thiyagarajan Thangavelu , MD

SERUM AUTOANTIBODIES DIRECTED TO THE GONADOTROPIN RELEASING HORMONE RECEPTOR ECL2 ARE DIAGNOSTIC OF PCOS
Myriam Elkosseifi, MD

AUTOMATED FREQUENT INSULIN DOSAGE TITRATIONS TO OVERCOME INSULINTHERAPY INEFFECTIVENESS
Israel Hodish, MD

Room: 17B
CME Code: 2472
12:00 pm – 2:15 pm Exhibit Hall Open
12:15 pm – 2:00 pm AACE Annual Business Meeting Luncheon
2:15 pm – 3:15 pm MEET-THE-EXPERTS SESSION I
  S11: Approach to Hypogonadal Men: Management Strategies
Moderator: Craig Wierum, MD
Speaker: Michael Irwig, MD


Room: 18AB
CME Code: 3774
  S21: Challenging Pituitary Cases
Moderator: Adriana Ioachimescu, MD
Speaker: Anne Klibanski, MD


Room: 19
CME Code: 9808
  S31: Skin & Endocrine Disorders: Beyond the Usual
Moderator: Catalina Poiana, MD
Speaker: Michelle Tarbox, MD


Room: 17B
CME Code: 5603
  S41: Molecular Markers in Thyroid Nodule Evaluation
Moderator: Enrico Papini, MD
Speaker: Yuri Nikiforov, MD


Room: 18CD
CME Code: 1440
  S51: Weight Management in Underserved Populations
Moderator: Ved Gossain, MD
Speaker: Jamy Ard, MD


Room: 16A
CME Code: 4728
  S61: Managing Transgender Youth
Moderator: Vin Tangpricha, MD
Speaker: Steve Rosenthal, MD


Room: 16B
CME Code: 7144
  S71: SGLT2 Inhibitors Town Hall: Renal Microscope - Benefits and Concerns
Moderator: W. Timothy Garvey, MD
Speakers: Ralph DeFronzo, MD;
Matthew Weir, MD


Room: 17A
CME Code: 1058
3:15 pm – 3:30 pm Coffee Break
3:30 pm – 4:30 pm MEET-THE-EXPERTS SESSION II
  S12: CGM in Pregnancy and Unique Populations
Moderator: Sandra Weber, MD
Speaker:Elizabeth Buschur, MD


Room: 16A
CME Code: 1349
  S22: Thyroid in Pregnancy and Newborn
Moderator: Leslie Eldeiry, MD
Speaker:Brian Casey,MD


Room: 17A
CME Code: 1884
  S32: Clinical Cases of Endocrine Hypertension
Moderator: M. Kathleen Figaro, MD
Speaker: Richard Auchus, MD


Room: 16B
CME Code: 1737
  S42: Approach to Hypogonadal Men: Management Strategies
Moderator: Craig Wierum, MD
Speaker: Michael Irwig, MD


Room: 18AB
CME Code: 7928
  S52: Challenging Pituitary Cases
Moderator: Adriana Ioachimescu, MD
Speaker: Anne Klibanski, MD


Room: 1827
CME Code: 19
  S62: Skin & Endocrine Disorders: Beyond the Usual
Moderator: Jimmy Aragon, MD
Speaker: Michelle Tarbox, MD


Room: 17B
CME Code: 1827
  S72: Molecular Markers in Thyroid Nodule Evaluation
Moderator: Jonathan Leffert, MD
Speaker: Yuri Nikiforov, MD


Room: 18CD
CME Code: 3921
4:45 pm – 5:45 pm MEET-THE-EXPERTS SESSION III
  S13: Weight Management in Underserved Populations
Moderator: Ved Gossain, MD
Speaker: Jamy Ard, MD


Room: 17B
CME Code: 4634
  S23: Managing Transgender Youth
Moderator: Ximena Lopez, MD
Speaker: Steve Rosenthal, MD


Room: 18AB
CME Code: 8908
  S33: SGLT2 Inhibitors Town Hall: Renal Microscope - Benefits and Concerns
Moderator: W. Timothy Garvey, MD
Speakers: Ralph DeFronzo, MD;
Matthew Weir, MD


Room: 18CD
CME Code: 8893
  S43: CGM in Pregnancy and Unique Populations
Moderator: Etie Moghissi, MD
Speaker:Elizabeth Buschur, MD


Room: 16A
CME Code: 2765
  S53: Thyroid in Pregnancy and Newborn
Moderator: Leslie Eldeiry, MD
Speaker: Brian Casey, MD


Room: 17A
CME Code: 9264
  S63: Clinical Cases of Endocrine Hypertension
Moderator: M. Kathleen Figaro, MD
Speaker: Richard Auchus, MD


Room: 16B
CME Code: 6562
  S73: Learning from Legends
Moderator: Elliot Sternthal, MD
Speakers:Lewis Braverman, MD


Room: 19
CME Code: 2801
6:30 pm ACE Convocation
7:30 pm President’s Gala

SUNDAY, MAY 7

7:00 am -11:00 am Attendee Registration
>7:30 am -12:00 pm CME Station Hours
8:00 am – 8:15 am General Session Announcements
8:15 am – 8:45 am SGS7: Multidisciplinary Approach to Endocrine Disease: MEN 2A
Moderator: Naifa L. Busaidy, MD
Panel: Naifa L. Busaidy, MD; David Terris, MD; Swati Mehrotra, MD


Room: Ballroom D
CME Code: 9041
8:45 am – 9:30 am SGS8: Multidisciplinary Approach to Endocrine Disease: Hypoparathyroidism
Moderator: Naifa L. Busaidy, MD
Panel: Naifa L. Busaidy, MD; David Terris, MD; Swati Mehrotra, MD


Room: Ballroom D
CME Code: 9939
9:30 am- 9:45 am Coffee Break
  President’s Announcements
9:45 am – 11:00 am SGS9: Multidisciplinary Approach to Endocrine Disease: Thyroid Cancer - Alpha to Omega
Co-Moderators: Peter Singer, MD; Greg Randolph, MD
Panel: Steve Sherman, MD; Yuri Nikiforov, MD


Room: Ballroom D
CME Code: 5632

Disclosure Information

Declaration of Disclosure and Conflicts of Interest

It is the policy of AACE to ensure balance, independence, objectivity, and scientific rigor in all of its CME activities. Presentation content may include discussion of an unlabeled use of a commercial product or an investigational use of a product not yet approved for any purpose. AACE requires that participating faculty disclose to the audience any product(s) and its use(s) discussed in the educational activity that are unapproved/unlabeled for the use by the FDA or still considered investigational in nature.

Everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships. “Relevant financial relationships” are financial relationships in any amount occurring within the past 12 months that create a conflict of interest. AACE requires speakers, faculty, CME Committee, and other individuals who are in a position to control the content of this educational activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly evaluated by AACE for fair balance, scientific objectivity of studies mentioned in the presentation, and educational materials used as basis for content, and appropriateness of patient care recommendations.

The intent of this disclosure is not to prevent a speaker with commercial affiliations from presenting, but rather to provide learners with information from which they may make their own judgments. Informed learners are the final safeguards in assuring that a CME activity is independent from commercial influence.

AACE has reviewed all disclosures and resolved or managed all identified conflicts of interest for this educational activity, as applicable.

CME Accreditation Committee Disclosures

Commercial Interest What Was Received For What Role
Myriam Allende-Vigo,
MD, MBA, FACP, FACE
Abbvie, Inc.
Janssen
Pharmaceuticals Inc.
Merck & Co., Inc.
Honoraria Speaker
David S.H. Bell,
MD, FACE, FACP
Novo Nordisk A/S
AstraZeneca
Janssen
Pharmaceuticals, Inc.
Honoraria Speaker
Stephen R. Crespin,
MD, FACE
Amgen, Inc. Fee Speaker
Israel Hartman,
MD, FACE
Bayer Healthcare AG,
Takeda Pharmaceutical Co. Ltd.,
Teva Pharmaceutical Industries

Eli Lilly & Co.
Novo Nordisk A/S

GlaxoSmithKline
Janssen Pharmaceuticals, Inc.
sanofi-aventis US LLC.
Research grant



Honoraria


Honoraria; research grant
Investigator



Speaker


Speaker; Investigator
Virginia A. LiVolsi,
MD
Veracyte, Inc Fees Histology consultant
Fernando Ovalle,
MD, FACE
Eli Lilly & Co
Novo Nordisk A/S
Janssen Pharmaceuticals, Inc.
sanofi-aventis US LLC

Medtronic, Inc.

Merck & Co., Inc.
AstraZeneca
GlaxoSmithKline
Pfizer, Inc.
GI Dynamics, Inc.
Honoraria; Research grant



Honoraria

Research grant
Consultant; Investigator



Consultant

Investigator
Philip Raskin,
MD, FACE
AstraZeneca Boehringer Ingelheim GmbH
Intarcia Therapeutics, Inc.
Eli Lilly & Co
Merck & Co. Inc.
Novo Nordisk A/S
Pfizer, Inc.

Boston Therapeutics, Inc. GlaxoSmithkline

Fee







Fee
Research support for the University of Texas Southwestern Medical Center



Advisor
Dace L. Trence,
MD, FACE
Medtronic, Inc.
sanofi-aventis U.S. LLC.
Stock Stockholder
Jagdeesh Ullal,
MD, FACE, ENCU
Novo Nordisk A/S


Corcept Therapeutics

Shire
Research grant


Honoraria
Principal investigator

Speaker

Advisory board
Jeff Unger,
MD, FACE
Janssen Pharmaceuticals, Inc.
Novo Nordisk A/S
Abbott
Honoraria Speaker Advisor

Nothing to Disclose
Joshua I. Barzilay, MD, FACE
Richard Correa, MD
Sina Jasim, MD, MPH
Phillip D.K. Lee, MD, FAAP, FACE
Dorothy S. Martinez, MD, FACE
Joseph M. Tibaldi, MD, FACE

Program Committee Disclosures

Commercial Interest What Was Received For What Role
Jamie Davidson,
MD, FACP, MACE
Program Committee
1. Aspire Bariatrics
2. Janssen
3. AstraZeneca/BMS

4. Novo Nordisk

5. Amgen, Inc.
6. Eli Lilly & Co.
7. Valeritas, Inc.
1. Honoraria
2. Honoraria
3. Honoraria

4. Honoraria

5. Honoraria
6. Honoraria
7. Honoraria
1. Consultant
2. Speaker Bureau
3. Advisory Board; Speaker
4. Advisory Board; Speaker
5. Advisory Board
6. Advisory Board
7. Advisory Board
Martin Grajower,
MD, FACP, FACE
Program Committee
1. Novo Nordisk A/S 1.Honoraria 1.Speaker/Corporate Ad Board
E. Michael Lewiecki,
MD, FACE
Program Committee
1. Eli Lilly & Co.
2. AbbVie, Inc.
3. Radius Health, Inc.
4. Alexion

5. Shire Co.

6. Amgen, Inc.

7. Merck & Co., Inc.
1. Grants
2. Honoraria
3. Honoraria
4. Honoraria

5. Honoraria

6. Grants; Honoraria

7. Grants; Honoraria
1. Investigator
2. Scientific Ad Board
3. Scientific Ad Board
4. Scientific Ad Board/Speaker
5. Scientific Ad Board/Speaker
6. Investigator; Scientific Ad Board
7. Investigator; Scientific Ad Board

Lance Sloan,
MD, FACE
Program Committee
1. AstraZeneca
2. BI/Eli Lilly
3. Janssen
4. Merck/Pfizer
1. Honoraria
2. Honoraria
3. Honoraria
4. Honoraria
1. Speaker
2. Speaker
3. Speaker
4. Speaker
Susan E. Williams,
MS, RD, MD, CCD, FACN, FACP
Program Committee
1. Johnson & Johnson
2. Shire Pharmaceuticals
1. Honoraria
2. Fees
1. Speaker
2. Consultant


Nothing to Disclose
Devaprabu Abraham, MD, MRCP, FACE, ECNU
Gary Edelson, MD, FACE
Moises Mercado, MD
Harmeet S. Narula, MD, FACP, FACE
Christine L. Twining, MD, FACE

Program Committee/Faculty Disclosures

Commercial Interest What Was Received For What Role
Kathleen Wyne,
MD, PhD, FNLA, FACE
Program Vice Chair;
Faculty
1. AbbVie, Inc.
2. Novo Nordisk A/S
3. Eli Lilly & Co.
4. Sanofi-aventis US LLC
1. Honoraria
2. Honoraria
3. Research support
4. Research support
1. Advisory Board
2. Advisory Board
3. Investigator
4. Investigator
Pauline M. Camacho,
MD, FACE,
Ex Officio, AACE President Program Committee;
Faculty
1. Amgen, Inc.

2. NPS Pharmaceuticals
1. Research grant/Ad Board
2. Research grant
1. PI

2. PI
Jeffrey I. Mechanick,
MD, FACN, FACP, FACE, ECNU, Ex Officio;
AACE President Program Committee;
Faculty
1.Abbott Nutrition 1.Honoraria 1.Lecture & Program Developement
George Grunberger,
MD, FACP, FACE,
Ex Officio,
AACE Immediate Past President Program Committee;
Faculty
1. Lexicon
2. Medtronic, Inc.
3. Boehringer Ingelheim
4. Janssen
5. Salix Pharmaceuticals
6. Sanofi-aventis US LLC
7. AstraZeneca

8. Eli Lilly & Co.

9. Novo Nordisk A/S

1. Research Support
2. Research Support
3. Honoraria
4. Honoraria
5. Honoraria
6. Honoraria
7. Honoraria/Research support
8. Honoraria/Research support
9. Honoraria/Research support
1. Investigator
2. Investigator
3. Speaker
4. Speaker
5. Speaker
6. Speaker
7. Speaker/Investigator

8. Speaker/Investigator

9. Speaker/Investigator
A. Jay Cohen,
MD, FACE
Program Committee;
Faculty
1. Janssen

2. Corcept Therapeutics

3. Endo International

4. AbbVie, Inc.
5. AstraZeneca
6. Boehringer Ingelheim
7. Eli Lilly & Co.

8. Merck & Co., Inc.

9. Novo Nordisk A/S

10. Sanofi-aventis US LLC
1. Honoraria

2. Honoraria

3. Honoraria

4. Honoraria
5. Honoraria
6. Honoraria
7. Honoraria; Research grant
8. Honoraria; Research grant
9. Honoraria; Research grant
10. Honoraria; Research grant
1. Speaker; Research Trials
2. Speaker; Advisory board
3. Speaker; Advisory board
4. Speaker
5. Speaker
6. Speaker
7. Speaker; Research trials
8. Speaker; Research trials
9. Speaker; Research trials
10. Speaker; Research trials
M. Kathleen Figaro,
MD, MS
Program Committee;
Faculty
1. Novo Nordisk A/S 1. Honoraria 1.Speaker
Jeffrey Garber,
MD, FACP, FACE
Program Committee;
Faculty
1. Kashiv Pharma
2. Titan Pharmaceuticals
3. Lio Tri Dev
1. Fees
2. Fees
3. Fees
1. Consultant
2. Consultant
3. Advisory board
Martin Grajower,
MD, FACP, FACE
Program Committee;
Faculty
1. Novo Nordisk A/S 1. Honoraria 1. Speaker/Corporate Ad Board
Chris K. Guerin,
MD, FACE, FNLA
Program Committee;
Faculty
1. Novo Nordisk A/S
2. Janssen

1. Honoraria
2. Honoraria
1. Speaker
2. Speaker/Consulting
Yehuda Handelsman,
MD, FACP, FACE, FNLA
Program Committee;
Faculty
1. Halozyme, Inc.
2. Intarcia Therapeutics
3. Lexicon
4. Takeda
5. Amarin, Corporation
6. Amylin
7. Janssen
8. Vivus, Inc.
9. Amgen, Inc.
10. Gilead
11. Merck & Co., Inc.
12. Sanofi-aventis US LLC
13. Boehringer Ingelheim

14. GlaxoSmithKline

15. Novo Nordisk A/S
1. Fees
2. Grant Support
3. Grant Support
4. Grant Support
5. Fees
6. Fees
7. Fees
8. Fees
9. Fees; Grant Support
10. Fees; Grant Support
11. Fees; Grant Support
12. Fees; Grant Support
13. Fees; Grant Support

14. Fees; Grant Support

15. Fees; Grant Support
1. Consultant
2. Research
3. Research
4. Research
5. Consultant/Speaker
6. Consultant/Speaker
7. Consultant/Speaker
8. Consultant/Speaker
9. Consultant; Research
10. Consultant; Research
11. Consultant; Research
12. Consultant; Research
13. Consultant/Speaker; Research
14. Consultant/Speaker; Research
15. Consultant/Speaker; Research
Edward S. Horton,
MD, FACE
Program Committee;
Faculty
1. Axon Pharma
2. PTS Diagnostics
3. Sanofi-Aventis US LLC
4. Takeda

5. Theracos, Inc

6. Amgen, Inc.
7. Merck & Co., Inc.
1. Honoraria
2. Honoraria
3. Honoraria
4. Honoraria

5. Honoraria

6. Honoraria
7. Honoraria
1. Advisory Board
2. Advisory Board
3. Advisory Board
4. Data safety monitoring board
5. Data safety monitoring board
6. Global Advisory Board
7. International speakers Bureau
Laurence Katznelson,
MD
Program Committee,
Faculty
1. Chiasma, Inc.
2. Novartis A/G
3. Versartis, Inc.
1.Honoraria
2.Research Grant
3.Research Grant
1. Consultant
2. Investigator
3. Investigator
Anne L. Leddy,
MD, FACE
Program Committee;
Faculty
1. Eli Lilly & Co.
2. PriMed Pharma
1. Fees
2. Fees
1. Speaker
2. Speaker
Jonathan D. Leffert,
MD, FACP, FACE, ECNU
Program Committee;
Faculty
1. Abbott
2. AbbVie, Inc.
3. Boehringer Ingelheim
4. Bristol-Myers Squibb
5. Eli Lilly & Co.
6. Johnson & Johnson Svs
7. Merck & Co., Inc.
8. Novo Nordisk A/S
9. Sanofi-aventis US LLC
1. Honoraria
2. Research grant
3. Research grant
4. Research grant
5. Research grant
6. Research grant


7. Research grant
8. Research grant
9. Research grant
1. Speaker
2. Investigator
3. Investigator
4. Investigator
5. Investigator
6. Investigator


7. Investigator
8. Investigator
9. Investigator
Matthew J. Levine,
MD, FACE
Program Committee;
Faculty
1. AbbVie, Inc.
2. AstraZeneca
3. Janssen
4. Boehringer Ingelheim
5. DexCom, Inc.

6. Eli Lilly & Co.
1. Honoraria
2. Honoraria
3. Honoraria
4. Intellectual Property
5. Consulting fees

6. Consulting fees
1. Speaker
2. Speaker
3. Speaker
4. Authoring an article
5. Advisory board member
6. Advisory panel participation
W. Reid Litchfield,
MD, FACE, ECNU
Program Committee;
Faculty
1.Novo 1.Honoraria 1. Speaker
Mark A. Lupo,
MD, FACE, ECNU
Program Committee;
Faculty
1. Veracyte, Inc.
2. Sanofi-aventis US LLC
3. Rosetta Genomics
4. AbbVie, Inc.
5. Eisai Co. Ltd.
6. Pathway Genomics
1. Funds
2. Honoraria
3. Honoraria
4. Honoraria
5. Honoraria
6. Honoraria
1. Research
2. Speaker/Advisor
3. Research/Advisor
4. Speaker
5. Speaker
6. Speaker
Janet B. McGill,
MD, FACE
Program Committee;
Faculty
1. Boehringer Ingelheim
2. AstraZeneca/BI

3. Lexicon

4. Novartis AG

5. Calibra Medical, Inc.
6. Dynavax Technologies
7. Intarcia Therapeutics
8. Merck & Co., Inc.
9. Novo Nordisk A/S
10. Valeritas, Inc.
11. DexCom, Inc.

12. Janssen
1. Consultant fee
2. Grant

3. Grant

4. Grant

5. Consultant fee
6. Consultant fee
7. Consultant fee
8. Consultant fee
9. Consultant fee
10. Consultant fee
11. Grant; Speaker fee

12. Consultant fee; Speaker fee
1. Consulting/Advisor
2. Washington University PI
3. Washington University PI
4. Washington University PI
5. Advisor
6. Advisor
7. Advisor
8. Advisor
9. Advisor
10. Advisor
11. Washington University PI; Speaker
12. Advisor; Speaker
Rachel Pessah-Pollack,
MD, FACE
Program Committee;
Faculty
1. Boehringer Ingelheim/Eli Lilly & Co. 1. Honoraria 1. Speaker
Robert Rapaport, MD
Program Committee; Faculty
1. Ferring Pharmaceuticals
2. Novo Nordisk A/S
3. Sandoz Pharmaceuticals
1. Honoraria
2. Honoraria
3. Honoraria
1. Speaker
2. Speaker
3. Speaker
Cheryl Rosenfeld,
DO, FACE, ECNU

Program Committee;
Faculty

1. Novartis AG
2. Boehringer Ingelheim
3. Eisai Co. Ltd.
4. AstraZeneca
5. Boehringer Ingelheim/Eli Lilly and Co.
6. Genzyme Corporation
7. Novo Nordisk A/S
8. Shire Co.

1. Editorial assistance
2. Consultant fee
3. Consultant fee
4. Honoraria
5. Honoraria

6. Honoraria
7. Honoraria
8. Honoraria
1. Author
2. Consultant
3. Consultant
4. Speaker
5. Speaker

6. Speaker
7. Speaker
8. Speaker
Aaron Vinik,
MD, PhD, FCP, MACP, FACE
Program Committee;
Faculty
1. Merck & Co., Inc.
2. Ionis Pharmaceuticals
3. Pfizer, Inc.
4. Alnylam Pharma
5. Astellas Pharma
6. Ipsen Group
7. Impeto Medical
8. Intarcia Therapeutics
9. Matrix Pharma
10. Nestle Health Science-Pamlab
11. Novo Nordisk A/S
12. Tercica Pharma
13. Veroscience
14. Viromed Co. Ltd.
1. Fees; Honoraria
2. Fees
3. Fees
4. Honoraria
5. Honoraria
6. Honoraria
7. Research grant
8. Research grant
9. Research grant
10. Research grant

11. Research grant
12. Research grant
13. Research grant
14. Research grant
1. Consultant; Speaker
2. Consultant
3. Consultant
4. Consultant
5. Consultant
6. Consultant
7. Principal investigator
8. Principal investigator
9. Principal investigator
10. Principal investigator

11. Principal investigator
12. Principal investigator
13. Principal investigator
14. Principal investigator
Sandra L. Weber,
MD, FACP, FACE
Program Committee;
Faculty
1. NIH
2. Novo Nordisk A/S
3. Sanofi-aventis US LLC
1. Research grant
2. Research grant
3. Research grant
1. Research, PI
2. Research, PI
3. Research, PI
Craig Wierum,
MD, FACE, ECNU
Program Committee;
Faculty
1. AstraZeneca
2. Boehringer Ingelheim/Eli Lilly & Co.
3. Novo Nordisk A/S
1. Honoraria
2. Honoraria

3. Honoraria
1. Speaker
2. Speaker

3. Speaker

Nothing to Disclose
S. Sethu Reddy, MD, MBA, FRCPC, FACP, MACE
Felice Caldarella, MD, FACP, CDE, FACE
Vin Tangpricha, MD, PhD, FACE
Steven A. De Jong, MD, FACS, FACE
Daniel L. Hurley, MD, FACE
David C. Lieb, MD, FACE
Mira Milas, MD
Karel Pacak, MD, PhD, DSc, FACE
Gregory Randolph, MD, FACS, FACE
Peter A. Singer, MD, FACE

Faculty Disclosures

Commercial Interest What Was Received For What Role
Myriam Z. Allende-Vigo,
MD, MBA, FACP, FACE
Faculty
1. AbbVie,Inc
2. Janssen
3. Merck & Co., Inc.
1. Honoraria
2. Honoraria
3. Honoraria
1. Speaker
2. Speaker
3. Advisor
Jamy D. Ard, MD
Faculty
1. Nestec Ltd.
2. Nestle Healthcare
3. Novo Nordisk A/S
1. Research grant
2. Fees
3. Honoraria
1. Research
2. Consultant
3. Advisory Board
Richard Auchus,
MD, PhD, FACE
Faculty
1. Millendo Therapeutics
2. Novartis Pharmaceuticals



3. Strongbridge Pharma


4. Alder BioPharmaceuticals
5. Corcept Therapeutics
6. Diurnal, Ltd.
7. Ipsen Pharmaceuticals
8. Janssen Pharmaceuticals
9. Spruce Biosciences
1. Contracted research support
2. Consulting fees; Contracted research support
3. Consulting fees: Contracted research support
4. Consulting fees
5. Consulting fees
6. Consulting fees
7. Consulting fees
8. Consulting fees
9. Consulting fees
1. Investigator
2. Consultant; Principal investigator


3. Advisory board; Principal investigator

4. Consultant
5. Consultant
6. Consultant
7. Consultant
8. Consultant
9. Consultant
Timothy Bailey,
MD, FACE
Faculty
1. Novo Nordisk A/S

2. Bayer Healthcare AG

3. Becton Dickinson & Co

4. Medtronic, Inc.

5. Sanofi-aventis US LLC

6. Abbot Laboratories
7. Acon Laboratories
8. Alere
9. Animas Corporation
10. Bristol-Myers Squibb
11. Cebix,Inc.
12. DexCom, Inc.
13. Eli Lilly & Co.
14. GlaxoSmithKline
15. Halozyme, Inc.
16. Insulet Corporation
17. Lifescan, Inc.
18. Mannkind Corp.
19. Merck & Co., Inc.
20. Orexigen
21. Tandem Diabetes
1. Honoraria; Research support
2. Honoraria; Research support
3. Honoraria; Research support
4. Honoraria; Research support
5. Honoraria; Research support
6. Research support
7. Research support
8. Research support
9. Research support
10. Research support
11. Research support
12. Research support
13. Research support
14. Research support
15. Research support
16. Research support
17. Research support
18. Research support
19. Research support
20. Research support
21. Research support
1. Consulting/Speaker; Researcher
2. Consulting; Researcher

3. Consulting; Researcher

4. Consulting; Researcher

5. Consulting; Researcher

6. Researcher
7. Researcher
8. Researcher
9. Researcher
10. Researcher
11. Researcher
12. Researcher
13. Researcher
14. Researcher
15. Researcher
16. Researcher
17. Researcher
18. Researcher
19. Researcher
20. Researcher
21. Researcher
David Bell, MD
Faculty
1. AstraZeneca
2. Janssen
3. Novo Nordisk A/S
1. Honoraria
2. Honoraria
3. Honoraria
1. Speaker
2. Speaker
3. Speaker

Thomas Blevins,
MD, FACE, ECNU
Faculty
1. Boehringer Ingelheim

2. AstraZeneca
3. Medtronic, Inc.
4. Merck & Co., Inc.
5. Eli Lilly & Co.

6. Novo Nordisk A/S

7. Sanofi-aventis US LLC
1. Clinical Research Support
2. Honoraria
3. Honoraria
4. Honoraria
5. Honoraria; Research support
6. Honoraria; Research support
7. Honoraria; Research support
1. Investigator

2. Speaker
3. Speaker
4. Speaker
5. Speaker; Investigator

6. Speaker; Investigator

7. Speaker; Investigator
Bruce Bode,
MD, FACE
Faculty
1. AstraZeneca
2. Eli Lilly
3. Merck & Co., Inc.
4. Abbott Laboratories

5. DexCom, Inc.

6. Halozyme, Inc.

7. MannKind Corporation

8. Janssen Pharmaceuticals


9. Medtronic, Inc


10. Novo Nordisk A/S


11. Sanofi-aventis US LLC
1. Honoraria
2. Honoraria
3. Honoraria
4. Research support to employer
5. Research support to employer
6. Research support to employer
7. Research support to employer
8. Consulting fees; Honoraria; Research support
9. Consulting fees; Honoraria; Research support to employer
10. Consulting fees; Honoraria; Research support to employer
11. Consulting fees; Honoraria; Research support to employer
1. Speaker
2. Speaker
3. Speaker
4. Principal investigator

5. Principal investigator



6. Principal investigator



7. Principal investigator



8. Advisory board, Speaker; Principal investigator
9. Consultant; Speaker; Principal investigator

10. Consultant; Speaker; Principal investigator

11. Consultant; Speaker; Principal investigator
Elise M. Brett,
MD, FACP, ECNU
Faculty
1. Novo Nordisk A/S 1. Salary 1. Spouse employed by company
Naifa Busaidy,
MD, FACE
Faculty
1. Eisai Co., Ltd.
2. Bayer Healthcare AG
1. Fee
2. Honoraria
1. Consultant
2. Advisory role
Michael A. Bush, MD
Faculty
1. Boehringer Ingelheim
2. Eli Lilly & Co.
3. Novo Nordisk A/S
4. AstraZeneca
5. Janssen
1. Honoraria
2. Honoraria
3. Honoraria
4. Honoraria
5. Honoraria
1. Speaker
2. Speaker
3. Speaker
4. Speaker; Consultant
5. Speaker; Consultant
Paresh Dandona,
MBBS, D.Phil., FRCP, FACP, FACC, FACE
Faculty
1. Bristol-Myers Squibb
2. Boehringer Ingelheim

3. AbbVie, Inc.

4. Astra Zeneca

5. Novo Nordisk A/S

6. Sanofi-aventis US LLC
1. Honoraria
2. Honoraria/Research grant
3. Honoraria; Research grant
4. Honoraria; Research grant
5. Honoraria

6. Honoraria
1. Global PI on research study
2. Advisory board
3. Speaker; Advisory board
4. Speaker; Advisory board
5. Speaker/Advisory board
6. Speaker/Advisory board
Ralph DeFronzo,
MD, BMS, MS, BS
Faculty
1. Takeda
2. Elcelyx Therapeutics
3. Intarcia Therapeutics
4. Novo Nordisk A/S

5. AstraZeneca

6. Boehringer Ingelheim

7. Janssen
1. Research Grant
2. Honoraria
3. Honoraria
4. Honoraria

5. Honoraria; Research Grant
6. Honoraria; Research Grant
7. Honoraria; Research Grant
1. Investigator
2. Advisory Board
3. Advisory Board
4. Speaker/Advisory Board
5. Speaker/Ad Board; Investigator
6. Advisory board; Investigator
7. Advisory board; Investigator
Sandeep Dhindsa,
MD, FACE
Faculty
1. AbbVie, Inc. 1. Honoraria 1. Speaker
Wael Eid,
MD, FACP, FACE, CDE
Faculty
1. Amgen, Inc.
2. Sanofi/Regeneron
1. Honoraria
2. Honororia
1. Speaker
2. Speaker
Raquel N. Faradji, MD
Faculty
1. Eli Lilly & Co.

2. Medtronic, Inc.

3. Novo Nordisk A/S
1. Honoraria

2. Honoraria; Travel Grants
3. Honoraria
1. Speaker/Advisory board
2. Speaker; Presentation of results in meetings
3. Speaker/Advisory board/PI
Maria Fleseriu,
MD, FACE
Faculty
1. Novartis 1. Research Support to Institution 1. Principle Investigator
Vivian Fonseca,
MD, FRCP, FACE
Faculty
1. Lexicon
2. Asahi Kasei Pharma

3. Bayer Healthcare AG

4. Eli Lilly & Co.

5. Gilead Sciences
1. Grant
2. Grant

3. Grant

4. Grant

5. Grant
1. Research support
2. Research support to Tulane
3. Research support to Tulane
4. Research support to Tulane
5. Research support to Tulane
Ken Fujioka, MD
Faculty
1. EnteroMedics, Inc.
2. AbbVie, Inc.
3. Ambra Health
4. Eisai Co. Ltd.
5. Gelesis Biotechnology
6. KVK Tech
7. Novo Nordisk A/S
8. Orexigen Therapeutics,
9. Shire Pharmaceuticals
1. Grant Support
2. Fee
3. Fee
4. Fee
5. Fee
6. Fee
7. Fee
8. Fee
9. Fee
1. Research
2. Speaker
3. Consulting
4. Consulting
5. Consulting
6. Consulting
7. Consulting/Speaker
8. Consulting/Speaker
9. Consulting/Speaker
W. Timothy Garvey,
MD, FACP, FACE
Faculty
1. AstraZeneca
2. Pfizer, Inc.
3. Merck & Co., Inc.

4. Eisai Co. Ltd.
5. Novo Nordisk A/S
6. Alexion Pharmaceuticals
7. Janssen Pharmaceuticals
8. Takeda Pharmaceuticals
9. Eli Lilly & Co.
10. ISIS Pharmaceuticals
11. Novartis AG
12. Elcelyx Therapeutics
13. Lexicon Pharmaceuticals
14. Sanofi-aventis US LLC
15. Weight Watcher’s
1. Honoraria
2. Grant; Stock
3. Grant; Stock; Honoraria
4. Grant; Honoraria
5. Grant; Honoraria
6. Honoraria
7. Honoraria
8. Honoraria
9. Stock
10. Stock
11. Stock
12. Grant
13. Grant
14. Grant
14. Grant
1. Research/Consultant
2. Research; Stockholder
3. Research; Stockholder; Consultant
4. Research; Consultant
5. Research; Consultant
6. Consultant
7. Consultant
8. Consultant
9. Stockholder
10. Stockholder
11. Stockholder
12. Research
13. Research
14. Research
15. Research
Richard E. Gilbert,
MD, PhD, FRCPC
Faculty
1. Janssen Pharmaceuticals
2. AstraZeneca

3. Boehringer Ingelheim
1. Honoraria
2. Honoraria; Research funding
3. Honoraria; Research funding
1. Speaker
2. Speaker; Researcher

3. Speaker; Researcher
Neil Goodman,
MD, FACE
Faculty
1. AbbVie, Inc. 1. Honoraria 1. Speaker
Ved V. Gossain,
MD, MACP, FRCP(C), FACE
Faculty
1. Novo Nordisk A/S 1. Honoraria 1. Speaker
William Grant,
DPM, FACFAS
Faculty
1. Royalty Pharma 1. Intellectual Property Rights 1. Speaker
Osama Hamdy,
MD, PhD, FACE
Faculty
1. HealthiNation
2. US Dairy Counsel
3. AstraZeneca
4. Abbott Laboratories
5. Merck
1. Stocks
2. Grant
3. Honoraria
4. Honoraria
5. Honoraria
1. Partner
2. Research
3. Advisory panel
4. Consultation
5. Consultation
Timothy Harlan,
MD, FACP
Faculty
1. www.DrGourmet.com 1. Book sales 1. Owner
Israel Hartman,
MD, FACE
Faculty
1. Amarin Corporation
2. AstraZeneca
3. Eli Lilly & Co.
4. GlaxoSmithKline
5. Novo Nordisk A/S
6. Sanofi-aventis US LLC
1. Honoraria
2. Honoraria
3. Honoraria
4. Honoraria
5. Honoraria
6. Honoraria
1. Speaker
2. Speaker
3. Speaker
4. Speaker
5. Speaker
6. Speaker
Bryan R. Haugen, MD
Faculty
1. Eisai Co., Ltd.
2. Genzyme Corporation
1. Research support
2. Research support
1. Consultant
2. Consultant
Irl B. Hirsch, MD
Faculty
1. Abbott Laboratories
2. Intarcia Therapeutics
3. Roche Co.
4. Valeritas, Inc.
1. Honoraria
2. Honoraria
3. Honoraria
4. Honoraria
1. Consultant
2. Consultant
3. Consultant
4. Consultant
Andrew R. Hoffman, MD Faculty 1. Ascendis Pharma
2. GeneScience Pharma
3. Genexine, Inc.
4. Pfizer, Inc.
5. Versartis, Inc.
1. Fees
2. Fees
3. Fees
4. Honoraria
5. Fees; Honoraria
1. Consultant
2. Consultant
3. Consultant
4. Speaker
5. Consultant; Speaker
Adriana G. Ioachimescu, MD, PhD, FACE
Faculty
1. Ionis Pharmaceuticals
2. Novartis AG

3. Pfizer, Inc.

4. Chiasma, Inc.


5. Ipsen Group
1. Consulting Fees
2. Research Grant (multicentric trial)
3. Research Grant (multicentric trial)
4. Research Grant (multicentric trial); Consulting fee
5. Research grant to Emory University; Consulting fee
1. Advisory committee
2. Principal Investigator

3. Principal Investigator

4. PI; Advisory Committee

5. PI; Advisory Committee
Scott D. Isaacs,
MD, FACP, FACE
Faculty
1. Orexigen Therapeutics
2. Novo Nordisk A/S
3. ABC TV Networks
1. Honoraria
2. Honoraria
3. Stipend
1. Speaker
2. Speaker/Consultant
3. Medical Consultant
Paul S. Jellinger,
MD, MACE
Faculty
1. AstraZeneca
2. Boehringer Ingelheim
3. Novo Nordisk A/S
1. Honoraria
2. Honoraria
3. Honoraria
1. Speaker
2. Speaker
3. Speaker
Shashank R. Joshi,
MD, DM, FRCP, FACE, FACP, FICP
Faculty
1. Franco Indian Pharma
2. Roche Diagnostics
3. USV Ltd.
4. AstraZeneca
5. Intas Pharmaceuticals
6. MSD Pharmaceutical
7. Bayer Zydus Pharma
8. Johnson & Johnson
9. Marico
10. Sanofi-aventis US LLC
11.Abbott Laboratories

12. Boehringer Ingelheim

13. Novartis AG

14. Novo Nordisk A/S

15. Pfizer, Inc.
1. Honoraria
2. Honoraria
3. Honoraria
4. Honoraria
5. Honoraria
6. Honoraria
7. Honoraria
8. Honoraria
9. Honoraria
10. Honoraria
11. Honoraria

12. Honoraria

13. Honoraria

14. Honoraria

15. Honoraria
1. Consultant
2. Advisory board
3. Advisor
4. Speaker
5. Speaker
6. Speaker
7. Speaker/Consultant
8. Speaker/Consultant
9. Speaker/Consultant
10. Speaker/Consultant
11. Speaker/Advisory board
12. Speaker/Advisory board
13. Speaker/Advisory board
14. Speaker/Advisory board
15. Speaker/Advisory board
Lee Kaplan, MD, PhD
Faculty
1. Ethicon US LLC
2. Fractyl Laboratories
3. Gelesis Biotechnology
4. GI Dynamics, Inc.
5. Janssen
6. Merck & Co., Inc.
7. Novo Nordisk A/S
8. Rhythm
9. Pfizer, Inc.
10. Zafgen, Inc.
1. Fees
2. Fees
3. Fees
4. Fees
5. Fees
6. Fees
7. Fees
8. Fees
9. Fees
10. Fees
1. Scientific consultant
2. Scientific consultant
3. Scientific consultant
4. Scientific consultant
5. Scientific consultant
6. Scientific consultant
7. Scientific consultant
8. Scientific consultant
9. Scientific consultant
10. Scientific consultant
M. Sue Kirkman, MD
Faculty
1. Bayer Healthcare AG
2. Novo Nordisk A/S
3. Theracos, Inc.
1. Research support
2. Research support
3. Research support
1. Investigator
2. Investigator
3. Investigator
Anne Klibanski, MD
Faculty
1. Chiasma, Inc.
2. Crinetics Pharmaceuticals
1. Honoraria
2. Honoraria
1. Consulting
2. Consulting
Howard Lando,
MD, FACP, FACE
Faculty
1. Pfizer, Inc.
2. Proctor & Gamble
3. Daiichi Sankyo Co Ltd.
4. Santarus, Inc.
5. Abbott Laboratories
6. AbbVie, Inc.
1. Stock
2. Stock
3. Honoraria
4. Honoraria
5. Honoraria; Stock
6. Honoraria; Stock
1. Stockholder
2. Stockholder
3. Speaker
4. Speaker
5. Speaker; Stockholder
6. Speaker; Stockholder
Ximena Lopez, MD
Faculty
1. AbbVie, Inc. 1. Honoraria 1. Advisory board
Ronald Ma,
MB BChir, FRCP (Edin, Lond), FHKCP, FHKAM
Faculty
1. Boehringer Ingelheim

2. AstraZeneca

3. Bayer Healthcare AG

4. MSD & Co., Inc.
1. Honoraria donated to CUHK
2. Research support to CUHK
3. Research support to CUHK
4. Research support to CUHK
1. Speaker

2. Clinical trials

3. Clinical trials

4. Clinical trials
Michael McClung,
MD, FACP, FACE
Faculty
1. Amgen
2. Radius
1.Fees; Honoraria
2.Consulting fees/Honoraria
1.Consultant; Speaker
2.Consultant
Michael McDermott, MD
Faculty
1. Sanofi-aventis US LLC
2. Shire Pharmaceuticals
1. Honoraria
2. Honoraria
1. Consultant
2. Consultant
Brian Michael,
MD, FACE, ECNU
Faculty
1. Veracyte, Inc. 1. Honoraria 1. Speaker
Etie S. Moghissi,
MD, FACP, FACE Faculty
1. Boehringer Ingelheim
2. Janssen
3. Takeda
4. AstraZeneca
5. Eli Lilly & Co.
6. Merck & Co., Inc.
7. Novo Nordisk A/S
1. Fees
2. Fees
3. Fees
4. Fees
5. Fees
6. Fees
7. Fees
1. Speaker
2. Speaker
3. Speaker
4. Consultant/Speaker
5. Consultant/Speaker
6. Consultant/Speaker
7. Consultant/Speaker
John E. Morley,
MB, BCh
Faculty
1. AbbVie, Inc.
2. Merck & Co, Inc.
1. Fee
2. Honoraria
1. Consultant
2. Editor – Merck Manual
Lynette Nieman,
MD, FACP
Faculty
1. HRA Pharma 1. Royalties 1. Invention
Yuri Nikiforov,
MD, PhD
Faculty
1. Quest Diagnositcs 1. Fee 1. Consultant
Christian Ochoa, MD
Faculty
Disclosure information forthcoming  
Steven Petak,
MD, JD, FCLM, MACE
Faculty
1. Amgen, Inc. 1. Honoraria 1. Speaker
Catalina Poiana,
MD, PhD, FACE, CCD
Faculty
1. Amgen Romania
2. Lilly Romania
3. MSD Pharmaceuticals
4. Novartis Oncology
1. Fee
2. Fee
3. Fee
4. Fee
1. Speaker
2. Speaker
3. Speaker
4. Advisory board
Richard Pratley, MD
Faculty
1. Lexicon
2. Sanofi-aventis US LLC
3. Boehringer Ingelheim
4. GlaxoSmithKline
5. Hanmi Pharma
6. Janssen
7. Ligand Pharma
8. Eli Lilly & Co
9. Merck & Co, Inc.
10. Takeda
11. AstraZeneca
12. Novo Nordisk A/S
1. Grant Support
2. Grant Support
3. Fees
4. Fees
5. Fees
6. Fees
7. Fees
8. Grant Support; Fees
9. Grant Support; Fees
10. Grant Support; Fees
11. Fees
12. Grant Support; Fees
1. Research
2. Research
3. Consultant
4. Consultant
5. Consultant
6. Consultant
7. Consultant
8. Research; Consultant
9. Research; Consultant
10. Research; Consultant
11. Speaker/Consultant
12. Research; Speaker/Consultant
Stephen M. Rosenthal, MD
Faculty
1. AbbVie, Inc. 1. Fee 1. Consultant
Susan Samson,
MD, PhD, FRCPC, FACE
Faculty
1. Chiasma, Inc.
2. Novartis AG
1. Honoraria
2. Honoraria; Grant
1. Advisory board
2. Advisory board; Investigator initiated
Valentin Sanchez, MD
Faculty
1. AstraZeneca
2. Novo Nordisk A/S
3. Sanofi-aventis US LLC
1. Honoraria
2. Honoraria
3. Honoraria
1. Speaker
2. Speaker
3. Speaker
Steven I. Sherman, MD
Faculty
1. Bristol-Myers Squibb
2. Eisai, Inc.
3. LOXO Oncology
4. Veracyte, Inc.
5. Genzyme Corporation
1. Fees
2. Fees
3. Fees
4. Fees
5. Fees; Research Support
1. Consultant
2. Consultant
3. Consultant
4. Consultant
5. Consultant; Research
Julie Ann Sosa,
MD, MA, FACS
Faculty
1. AstraZeneca
2. Eli Lilly & Co.


3. GlaxoSmithKline

4. Novo Nordisk A/S
1. Consulting Fee
2. Consulting Fee


3. Consulting Fee

4. Consulting Fee
1. Member, DMC, MTC Consortium Registry
2. Member, DMC, MTC Consortium Registry
3. Member, DMC, MTC Consortium Registry
4. Member, DMC, MTC Consortium Registry
William Tamborlane, MD
Faculty
1. AstraZeneca
2. Boehringer Ingelheim
3. Insuline Medical Ltd.
4. Janssen
5. Medtronic, Inc.
6. Novo Nordisk A/S
7. Sanofi-aventis US LLC
8. Takeda
1. Fees
2. Fees
3. Fees
4. Fees
5. Fees
6. Fees
7. Fees
8. Fees
1. Consultant
2. Consultant
3. Consultant
4. Consultant
5. Consultant
6. Consultant
7. Consultant
8. Consultant
David Terris, MD, FACS
Faculty
1. Genzyme Corporation 1. Honoraria 1. Director, Thyroid Course
Kenneth Tomecki, MD
Faculty
Disclosure information forthcoming
Dace Trence, MD, FACE
Faculty
1. Medtronic, Inc.
2. Sanofi-aventis US LLC
1. Stock
2. Stock
1. Stockholder
2. Stockholder
R. Michael Tuttle, MD
Faculty
1. Bayer AG/Onyx
2. Eisai Co. Ltd.
3. Genzyme/Sanofi
4. Novo Nordisk A/S
5. Veracyte, Inc.
1. Honoraria
2. Honoraria
3. Honoraria
4. Honoraria
5. Honoraria
1. Consultant
2. Consultant
3. Consultant
4. Consultant
5. Consultant
Nelson Watts,
FACP, MACE
Faculty
1.. AbbVie, Inc.
2. Radius Health, Inc.
3. Merck & Co., Inc.
4. Amgen, Inc.
5. Shire Plc

6. OsteoDynamics .
1. Fees
2. Fees
3. Honoraria
4. Honoraria; Fees
5. Honoraria; Research support
6. Stock options/Holdings/Royalties
1. Consultant
2. Consultant
3. Lectures
4. Lectures; Consultant
5. Lectures; Clinical trials
6. Co-founder/Stockholder/Director (Resigned within the last 12 months)
Michael R. Weir, MD
Faculty
1. AstraZeneca
2. Boehringer-Ingelheim
3. Boston Scientific
4. Janssen
5. Merck & Co., Inc.
6. Relypsa, Inc.
7. Sanofi-aventis US LLC
1. Honoraria
2. Honoraria
3. Honoraria
4. Honoraria
5. Honoraria
6. Honoraria
7. Honoraria
1. Scientific advisor
2. Scientific advisor
3. Scientific advisor
4. Scientific advisor
5. Scientific advisor
6. Scientific advisor
7. Scientific advisor
William D. Zigrang,
MD, CCD, FACE
Faculty
1. Eli Lilly & Co.
2. AstraZeneca

3. Bristol-Myers Squibb Co

4. Janssen
1. Reimbursement
2. Honoraria

3. Honoraria

4. Honoraria
1. Contracted research
2. Speaker/Speaker training
3. Speaker/Speaker training
4. Speaker/Speaker training

Nothing to Disclose
Jimmy B. Aragon, MD, FACE
David G. Armstrong, DPM, MD, PhD
Larissa Avile-Santa, MD, MPH, FACP, FACE
Alejandro R. Ayala, MD
Rashika Bansal, MD
Conor Best, MD
Neil Binkley, MD
Andrew J. M. Boulton, MD, DSc (Hon), FACP, FICP, FRCP
Lewis Braverman, MD, FACE
Stuart Brink, MD
Elizabeth Buschur, MD
Robert Califf, MD
Bruce R. Carr, MD
Brian Casey, MD
Kelly Chiles, MD, MSc
Tim Church, MD, PhD
Lauren Clarine, DO
Rhoda Cobin, MD, MACE, ECNU
Leslie Eldeiry, MD, FACE, ECNU
Charles Faiman, MD, FRCPC, MACE
Judith Fradkin, MD
Hossein Gharib, MD, MACP, MACE
Jennifer Glueuck, MD
Guillermo Gonzalez-Galvez, MD
Richard A. Haas, MD, FACE
Amir H. Hamrahian, MD, FACE
R. Mack Harrell, MD, FACP
Michael S. Irwig, MD, FACE
John Kanis, MD
Gerard Karsenty, MD, PhD
Brian Kim, MD
Bill Law, Jr., MD, FACE, FACP, ECNU
Edward Laws, Jr., MD, FACS
William D. Leslie, MD, FRCPC, MSc
Swati Mehrotra, MD
Karl Nadolsky, DO
Sondra O’Callaghan, PA-C, MPH, CHES
Robert M. Palmer, MD, MPH, FACP
Enrico Papini, MD, FACE
Anastassios Pittas, MD, MS
Claudia Ramirez-Renteria, MD, MSc
Jill Rathbun, MHSA
Matthew Ringel, MD
Clifford Rosen, MD
Douglas S. Ross, MD
Daniel T. Ruan, MD, FACS
Charles Sklar, MD
Elliot Sternthal, MD, FACP, FACE
Michelle Tarbox, MD, FAAD
Hanford Yau, MD, CCD

*designates a member of both faculty and program committee